Adenotonsillectomy for obstructive sleep apnoea in children with Down Syndrome – No magic bullet.

1,2Al Shidanhi K, 1,2McNally P
1Department of Respiratory Medicine, Our Lady’s Children’s Hospital
2Department of Paediatrics, Royal College of Surgeons in Ireland.

Obstructive Sleep Apnea (OSA) is common in children with Down Syndrome (DS). Various studies report the prevalence of OSA in DS at 30-60 % while only 1-5% of healthy children have OSA1,2. In children with a diagnosis of OSA, the first step in clinical management involves a determination of whether OSA may be surgically reversible in the short term. The American Academy of Paediatrics (AAP) recommends adenotonsillectomy as the first line treatment for children with OSA and adenotonsillar hypertrophy. In otherwise healthy, non-obese children, the success rate of adenotonsillectomy is approximately 80%3. The very different risk factors for OSA in children with DS would suggest that adenotonsillectomy is likely to be less successful in this group. Clinically, the decision as to whether or not to perform adenotonsillectomy in a child with DS and OSA is difficult, with limited evidence to guide decisions. The most difficult question is usually whether or not to proceed with surgery in those with only mild enlargement of tonsils and/or adenoids. The alternative for this group is Continuous Positive Airway Pressure (CPAP) – not an insignificant undertaking in a child with DS. In their paper earlier this year in Archives of Disease in Childhood, Maris et al sought to assess the effectiveness of adenotonsillectomy for OSA in children with DS4. In this single centre retrospective study the primary outcome measure was the Obstructive Apnoea Hypopnoea Index (OAHI). The authors showed a significant reduction of mean OAHI in children with DS. The greatest benefit was seen in those with a high OAHI. A significant proportion of children, however still had an OAHI in the abnormal range after adenotonsillectomy.

This was the largest series of children with DS and OSA reported in the literature to date, and all patients in the study had undergone full polysomnography before and after adenotonsillectomy. The authors clearly describe their findings and demonstrate a significant reduction in mean OAHI without changes in sleep stage distribution or efficiency. The study however has several limitations that impact on its generalisability to the children with DS we care for in our clinics. The authors mention, but do not expand on, a score for tonsil size. Specifically, no effort is made to stratify children into groups based on adenotonsillar size or Mallampati classification of pharyngeal shape. This would be very useful clinically to help us to decide who may require surgery. Neither did the authors make an effort to understand which clinical features, either on history or examination, were associated with successful reduction of OAHI. It is interesting to note that much of the reduction in mean OAHI in this study was explained by significant reductions in a few patients.

Although OAHI is an objective marker of obstructive sleep apnoea, significant night to night variability in OAHI is well recognised in children5. In addition to this, clinical practice in Europe in particular has evolved to understand that an isolated elevated OAHI alone is not sufficient to warrant treatment unless accompanied by typical symptoms of OSA. Clinical management of children with suspected OSA is therefore based heavily on clinical symptoms, both during sleep but also during the day. Unfortunately this was not something that was reported in this study. In healthy children with OSA without intervention, OAHI when measured serially is likely to decline with age after toddlerhood3. No similar data is available for children with DS. Therefore the lack of a suitable control group here leaves us guessing whether with watchful waiting a similar reduction of OAHI would have been seen.

Overall, therefore we are really no further on in our understanding of the natural history of OSA or requirement for adenotonsillectomy in individuals with DS. The current practice of individualized clinical judgement as to whether or not removal of adenotonsillar tissue is likely to result in improvements in a dynamic airway obstruction in a given patient during sleep is therefore not likely to change. A prospective randomised trial of adenotonsillectomy in children with DS is required. This would need high patient numbers and an array of clinically relevant endpoints in addition to OAHI.

McNally P, Department of Respiratory Medicine, Our Lady’s Children’s Hospital, Department of Paediatrics, Royal College of Surgeons in Ireland.
Email: [email protected]

1) Maris M, Verhulst S, Wojciechowski M, Van de Heyning P, Boudewyns A. Prevalence of Obstructive Sleep Apnea in Children with Down Syndrome. Sleep. 2016 Mar 1;39(3):699-704. doi: 10.5665/sleep.5554. PubMed PMID: 26612391; PubMed Central PMCID: PMC4763351.

2) Marcus CL, Brooks LJ, Draper KA, Gozal D, Halbower AC, Jones J, Schechter MS, Ward SD, Sheldon SH, Shiffman RN, Lehmann C, Spruyt K; American Academy of Pediatrics. Diagnosis and management of childhood obstructive sleep apnea syndrome. Pediatrics. 2012 Sep;130(3):e714-55. doi: 10.1542/peds.2012-1672. Epub 2012 Aug 27. Review. PubMed PMID: 22926176.

3) Marcus CL, Moore RH, Rosen CL, Giordani B, Garetz SL, Taylor HG, Mitchell RB, Amin R, Katz ES, Arens R, Paruthi S, Muzumdar H, Gozal D, Thomas NH, Ware J, Beebe D, Snyder K, Elden L, Sprecher RC, Willging P, Jones D, Bent JP, Hoban T, Chervin RD, Ellenberg SS, Redline S; Childhood Adenotonsillectomy Trial (CHAT). A randomized trial of adenotonsillectomy for childhood sleep apnea. N Engl J Med. 2013 Jun 20;368(25):2366-76. doi: 10.1056/NEJMoa1215881. Epub 2013 May 21. PubMed PMID: 23692173; PubMed Central PMCID: PMC3756808.

4) Maris M, Verhulst S, Wojciechowski M, Van de Heyning P, Boudewyns A. Outcome of adenotonsillectomy in children with Down syndrome and obstructive sleep apnoea. Arch Dis Child. 2017 Apr;102(4):331-336. doi: 10.1136/archdischild-2015-310351. Epub 2016 Aug 2. PubMed PMID: 27484971.

5) Katz ES, Greene MG, Carson KA, Galster P, Loughlin GM, Carroll J, Marcus CL. Night-to-night variability of polysomnography in children with suspected obstructive sleep apnea. J Pediatr. 2002 May;140(5):589-94. PubMed PMID: 12032527.